The effects of Mindfulness Meditation on hallucination and delusion in severe schizophrenia patients with more than 20 years’ medical history
Jia-Ling Sheng, Yan Yan, Xianghong Yang, Ti-Fei Yuan, Dong-Hong Cui
CNS Neuroscience & Therapeutics September 28, 2018 DOI: 10.1111/cns.13067 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case report Peer reviewed |
|---|---|
| Sample size | 5 |
| Population | Five male chronic schizophrenia patients with severe, drug-treatment-resistant hallucinations and delusions, average age 55.8 years and average medical history of 30.2 years |
| Intervention | Mindfulness meditation |
| Duration | 8-month intervention with follow-up at 1, 2, 3, 4, 5, 6, 7, 8 weeks and 8 months |
| Measures | Positive and Negative Syndrome Scale (PANSS), Short Form-36 Health Survey (SF-36), Five Facet Mindfulness Questionnaire (FFMQ) |
| Topics | Meditation |
| Key findings | The authors report that in five chronic schizophrenia patients, hallucinations and delusions had persisted without change for the prior eight years and showed little change during the first two weeks of an eight-month mindfulness meditation intervention. The letter does not report results beyond that point in the available text. |
Abstract
Dear Editor, Mindfulness meditation alleviates symptoms of distress, pain, and many chronic diseases.1‒3 In schizophrenic patients, mindfulness intervention leads to better psychosocial functioning,4 improved positive emotions,5 and reduced negative symptoms.6 It is unknown if mindfulness meditation could reduce positive symptoms in the chronic schizophrenia patients. Five male patients, averaged age at 55.80 ± 9.45 years old (ranged 44‐66 years), with averaged medical history of 30.20 ± 8.53 years (ranged 21‐41 years) were recruited for present study. All patients received active antipsychotics treatment upon admission (at higher doses than patients on average): chlorpromazine equality averaged at 670.00 ± 176.47 mg/d (ranged 487.5‐900). These patients demonstrated severe and drug treatment‐re‐ sistant hallucination/delusions (score >5; Details in Table 1). The Positive and Negative Syndrome Scale (PANSS), Short Form‐36 Health Survey (SF‐36), and Five Facet Mindfulness Questionnaire (FFMQ) were measured by an expert clinical psychologist. The study has been approved by the ethic committee of medical research in the Minzheng hospital, and written informed consents were obtained from all patients for the study, or the guardians/next of kin of these participants when in need. Informed consent was as well obtained for the publication of this case report. This clin‐ ical trial has been registered on the Chinese Clinical Trial Registry (https://www.chictr.org.cn/index.aspx). The registration number is ChiCTR‐OOB‐17014038. Registered December 19, 2017 (retro‐ spectively registered). Timeline: February 2017: Recruitment of patients and start of the trial. Intervention: 8 months, group intervention, and individual training. Follow‐up: 1, 2, 3, 4, 5, 6, 7, 8 weeks and 8 months after start point of intervention for the hallucination and delusion symptoms, and relevant scales. Mindfulness meditation was performed with following proce‐ dures. In the first 8 weeks, the group intervention (90 minutes each, led by two experienced tutors) was conducted per week, and after the period, the group intervention frequency was once per month. During the continuous 8 months period, the patients performed mindfulness meditation per day for 20‐40 minutes. The records were double checked and confirmed by the tutors. The data were an‐ alyzed with SPSS 18.0 software (SPSS Inc., Chicago, IL, USA); paired‐ sample t test was used for differences before and after intervention. The hallucination and delusion symptoms persisted and exhib‐ ited no change during the past 8 years (measured at 8 years ago, 4 years ago, 2 weeks ago, and baseline time point) prior to this study. Following mindfulness training intervention, the hallucination and delusion symptoms did not exhibit much change in the first 2 weeks
Comparable studies
Other case reports and case series on meditation, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Brain sources of EEG gamma frequency during volitionally meditation-induced, altered states of consciousness, and experience of the self Advanced meditator | 2001 | Case study | n = 1 |
| Mindfulness Meditation for Alcohol Relapse Prevention: A Feasibility Pilot Study Adult alcohol-dependent graduates of an intensive outpatient program | 2008 | Prospective case series | n = 19 |
| How does it feel to lack a sense of boundaries? A case study of a long-term mindfulness meditator. A single long-term mindfulness practitioner (S) with 40 years of practice in... | 2015 | Qualitative case study | n = 1 |
| Loving‐kindness meditation to enhance recovery from negative symptoms of schizophrenia Individuals suffering from schizophrenia-spectrum disorders with persistent negative... | 2009 | Case study | |
| Mindfulness-Based Cognitive Therapy for Problem Gambling A female problem gambler | 2011 | Case study | n = 1 |
Citations in the library
Cited by 9
- Real-time fMRI neurofeedback reduces auditory hallucinations and modulates resting state connectivity of involved brain regions: Part 2: Default mode network -preliminary evidence Psychiatry Research January 14, 2020
- Biological mechanism study of meditation and its application in mental disorders General Psychiatry July 13, 2020
- Effects of mindfulness-based interventions (MBIs) on psychotic symptoms and psychological outcomes in patients with schizophrenia spectrum disorders: A systematic review and meta-analysis. Psychiatry Research December 1, 2024
- Eight-month intensive meditation-based intervention improves refractory hallucinations and delusions and quality of life in male inpatients with schizophrenia: a randomized controlled trial. Psychiatry and Clinical Neurosciences April 1, 2024
- Exploring the mind-brain relationship to advance mental health research and practice Current Psychology December 1, 2025
and 4 more in the library
Cites 5
- Mindfulness‐Based Cognitive Therapy for Nonremitted Patients with Bipolar Disorder CNS Neuroscience & Therapeutics April 2, 2011
- Meditation is associated with increased brain network integration. Neuroimage September 1, 2017
- Mindfulness meditation improves metabolic profiles in healthy and depressive participants CNS Neuroscience & Therapeutics February 5, 2018
- Mindfulness mediates the physiological markers of stress: Systematic review and meta-analysis. Journal of Psychiatric Research August 23, 2017
- A pilot study of loving-kindness meditation for the negative symptoms of schizophrenia. Schizophrenia Research July 1, 2011